
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $304.4M | -- | -- | -- | -- |
08/08/2025 | Q2 | $295.9M | -- | -- | -- | -- |
05/12/2025 | Q1 | $36.9M | $47.2M | -$0.66 | -- | -- |
02/26/2025 | Q4 | $48.2M | $52.1M | -$0.31 | -- | -- |
11/06/2024 | Q3 | $282.4M | $290.7M | $0.16 | -- | -- |
08/08/2024 | Q2 | $279.8M | $282.9M | $0.47 | -- | -- |
05/08/2024 | Q1 | $37.3M | $37.1M | -$0.83 | -- | -- |
02/28/2024 | Q4 | $50.7M | $67.7M | -$0.52 | -- | -- |
11/03/2023 | Q3 | $268.8M | $271.8M | -$0.10 | -- | -- |
08/04/2023 | Q2 | -- | $270.1M | -$0.47 | -- | -- |
05/05/2023 | Q1 | $32.6M | $31M | -$0.94 | -- | -- |
03/01/2023 | Q4 | -- | $71.3M | -$0.85 | -- | -- |
11/04/2022 | Q3 | -- | $245.4M | -$0.48 | -- | -- |
08/05/2022 | Q2 | -- | $250.3M | $1.20 | -- | -- |
05/06/2022 | Q1 | -- | $23M | -$0.25 | -- | -- |
02/25/2022 | Q4 | -- | $102M | -$0.25 | -- | -- |
11/04/2021 | Q3 | -- | $234M | $0.69 | -- | -- |
08/06/2021 | Q2 | -- | $216M | $0.39 | -- | -- |
05/07/2021 | Q1 | -- | $16M | -$1.13 | -- | -- |
02/26/2021 | Q4 | -- | $35M | -$1.22 | -- | -- |
11/05/2020 | Q3 | -- | $110M | -$0.61 | -- | -- |
08/10/2020 | Q2 | -- | $11M | -$0.75 | -- | -- |
03/31/2020 | Q1 | -- | $22M | -$0.69 | -- | -- |
02/26/2020 | Q4 | -- | $34M | -$0.86 | -- | -- |
11/11/2019 | Q3 | -- | $212M | $0.16 | -- | -- |
08/08/2019 | Q2 | -- | $208M | $0.46 | -- | -- |
05/09/2019 | Q1 | -- | $22M | -$1.39 | -- | -- |
02/28/2019 | Q4 | -- | $32M | $0.35 | -- | -- |
11/08/2018 | Q3 | -- | $200M | $0.80 | -- | -- |
08/08/2018 | Q2 | -- | $182M | -$0.04 | -- | -- |
05/09/2018 | Q1 | -- | $28M | -$1.02 | -- | -- |
03/01/2018 | Q4 | -- | $20M | $0.08 | -- | -- |
11/09/2017 | Q3 | -- | $185M | $0.45 | -- | -- |
08/09/2017 | Q2 | -- | $176M | -$0.04 | -- | -- |
05/09/2017 | Q1 | -- | $5M | -$1.00 | -- | -- |
02/28/2017 | Q4 | -- | $18M | -$0.16 | -- | -- |
11/08/2016 | Q3 | -- | $109M | -$0.45 | -- | -- |
06/30/2016 | Q2 | -- | $131M | $0.11 | -- | -- |
03/31/2016 | Q1 | -- | $4M | -$0.71 | -- | -- |
Atlanta Braves Holdings reported $47.2M worth of top line sales in its most recent quarter.
Atlanta Braves Holdings announced earnings per share of -$0.66 which represents a miss of analyst forecast a -- per share.
Atlanta Braves Holdings reported -$4M that represents -$0.06 per share over the last quarter.
Atlanta Braves Holdings's earnings are forecast to grow from -$0.50 per share to -- per share next year representing an increase of --.
Atlanta Braves Holdings's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.